Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients.

By P. Simon, Marie T. Kasimir, G. Seebacher, G. Weigel, R. Ullrich, U. Salzer-Muhar, E. Rieder, E. Wolner. European Journal of Cardio-Thoracic Surgery, 2003

650 citations recorded by the source corpus.

Subfields: Biomaterials, Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0146261c2e4cdcc8e6fb23d12d365c9da0666dff

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. G. Vunjak‐Novakovic
2. A. Atala
3. A. Mikos

In Surgery

1. A. Atala
2. A. Mikos

Citations in the corpus

• Engineering Complex Tissues (2006, positive): “used SynerGraft decellularized porcine heart valves as homograft valve replacements in the right ventricular outflow tract during Ross procedures in children.(184) Many valves failed, and postimplant examination of failed valves revealed incomplete decellularization, lack of cell repopulation, lack ”
• Calcification of tissue heart valve substitutes: progress toward understanding and prevention. (2005, methodology): “Such an approach has been used on nonfixed homografts which were clinically implanted, yielding unfavorable results [89, 90].”